# MONTE ROSA THERAPEUTICS INC (GLUE)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/GLUE/

- Reporting holders: 3
- Reported value: $41.9K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $24.1K | 2,023 | 0.0% | 4 |
| [Paladin Partners, LLC](https://holderbook.com/funds/2141570-paladin-partners-llc/) | $11.9K | 1,000 | 0.0% | 2 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $5.8K | 489 | 0.0% | 4 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 3 | $41.9K |
| Q2 2026 | 196 | $2.4B |
| Q1 2026 | 191 | $1.4B |
| Q4 2025 | 161 | $1.0B |
| Q3 2025 | 128 | $450.8M |
| Q2 2025 | 118 | $283.2M |
| Q1 2025 | 107 | $276.9M |
| Q4 2024 | 108 | $425.7M |
| Q3 2024 | 82 | $264.8M |
| Q2 2024 | 76 | $172.2M |
| Q1 2024 | 69 | $282.9M |
| Q4 2023 | 72 | $231.3M |